肠道微生物群对肥胖、糖尿病和心血管疾病风险的影响。
Impact of Gut Microbiota on Obesity, Diabetes, and Cardiovascular Disease Risk.
作者信息
Miele Luca, Giorgio Valentina, Alberelli Maria Adele, De Candia Erica, Gasbarrini Antonio, Grieco Antonio
机构信息
Institute of Internal Medicine, Policlinico Gemelli Hospital, Catholic University of Sacred Heart of Rome, Rome, Italy.
Clinical Division of Internal Medicine, Gastroenterology and Liver Unit, Complesso Integrato Columbus Hospital, Catholic University of Sacred Heart of Rome, Rome, Italy.
出版信息
Curr Cardiol Rep. 2015 Dec;17(12):120. doi: 10.1007/s11886-015-0671-z.
Gut microbiota has been recently established to have a contributory role in the development of cardiometabolic disorders, such as atherosclerosis, obesity, and type 2 diabetes. Growing interest has focused on the modulation of gut microbiota as a therapeutic strategy in cardiovascular diseases and metabolic disorders. In this paper, we have reviewed the impact of gut microbiota on metabolic disorders and cardiovascular disease risk, focusing on the newest findings in this field.
最近已证实，肠道微生物群在心血管代谢紊乱（如动脉粥样硬化、肥胖症和2型糖尿病）的发展中起作用。越来越多的研究兴趣集中在调节肠道微生物群，将其作为心血管疾病和代谢紊乱的一种治疗策略。在本文中，我们综述了肠道微生物群对代谢紊乱和心血管疾病风险的影响，重点关注该领域的最新研究结果。
Zotero 插件